Create Medic Co., Ltd. (TYO:5187)
Japan · Delayed Price · Currency is JPY 1,073.00
-5.00 (-0.46%)
At close: Jan 23, 2026
Create Medic Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 13,572 | 13,030 | 12,585 | 12,257 | 11,698 | 10,830 | Upgrade | |
Revenue Growth (YoY) | 4.97% | 3.54% | 2.68% | 4.78% | 8.02% | -0.12% | Upgrade |
Cost of Revenue | 7,516 | 7,326 | 7,107 | 6,883 | 6,438 | 5,753 | Upgrade |
Gross Profit | 6,056 | 5,704 | 5,478 | 5,374 | 5,260 | 5,077 | Upgrade |
Selling, General & Admin | 4,970 | 5,011 | 4,675 | 4,636 | 4,393 | 4,092 | Upgrade |
Operating Expenses | 4,970 | 5,011 | 4,675 | 4,636 | 4,393 | 4,092 | Upgrade |
Operating Income | 1,086 | 693 | 803 | 738 | 867 | 985 | Upgrade |
Interest Expense | -9 | -10 | -10 | -7 | -6 | -7 | Upgrade |
Interest & Investment Income | 39 | 42 | 35 | 42 | 43 | 33 | Upgrade |
Currency Exchange Gain (Loss) | -59 | 3 | 26 | 26 | 84 | -60 | Upgrade |
Other Non Operating Income (Expenses) | 21 | 23 | 23 | 11 | 26 | 5 | Upgrade |
EBT Excluding Unusual Items | 1,078 | 751 | 877 | 810 | 1,014 | 956 | Upgrade |
Gain (Loss) on Sale of Investments | - | -29 | -24 | - | -75 | -3 | Upgrade |
Gain (Loss) on Sale of Assets | -30 | 297 | -5 | 4 | -5 | -4 | Upgrade |
Asset Writedown | -143 | -23 | - | - | - | - | Upgrade |
Other Unusual Items | 197 | 89 | 56 | 22 | 31 | 34 | Upgrade |
Pretax Income | 1,102 | 1,085 | 904 | 836 | 965 | 983 | Upgrade |
Income Tax Expense | 340 | 245 | 750 | 376 | 305 | 324 | Upgrade |
Net Income | 762 | 840 | 154 | 460 | 660 | 659 | Upgrade |
Net Income to Common | 762 | 840 | 154 | 460 | 660 | 659 | Upgrade |
Net Income Growth | -14.29% | 445.46% | -66.52% | -30.30% | 0.15% | -9.10% | Upgrade |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade |
Shares Change (YoY) | -2.91% | -3.17% | 0.05% | 0.03% | -1.83% | -0.55% | Upgrade |
EPS (Basic) | 89.37 | 95.31 | 16.92 | 50.56 | 72.57 | 71.13 | Upgrade |
EPS (Diluted) | 87.82 | 95.31 | 16.92 | 50.56 | 72.57 | 71.13 | Upgrade |
EPS Growth | -11.72% | 463.32% | -66.54% | -30.33% | 2.02% | -8.60% | Upgrade |
Free Cash Flow | - | 1,865 | 263 | 201 | 949 | 1,021 | Upgrade |
Free Cash Flow Per Share | - | 211.60 | 28.89 | 22.09 | 104.34 | 110.21 | Upgrade |
Dividend Per Share | 20.000 | 37.000 | 37.000 | 37.000 | 37.000 | 37.000 | Upgrade |
Dividend Growth | -45.95% | - | - | - | - | - | Upgrade |
Gross Margin | 44.62% | 43.78% | 43.53% | 43.84% | 44.96% | 46.88% | Upgrade |
Operating Margin | 8.00% | 5.32% | 6.38% | 6.02% | 7.41% | 9.10% | Upgrade |
Profit Margin | 5.62% | 6.45% | 1.22% | 3.75% | 5.64% | 6.08% | Upgrade |
Free Cash Flow Margin | - | 14.31% | 2.09% | 1.64% | 8.11% | 9.43% | Upgrade |
EBITDA | 1,758 | 1,329 | 1,391 | 1,338 | 1,329 | 1,390 | Upgrade |
EBITDA Margin | 12.95% | 10.20% | 11.05% | 10.92% | 11.36% | 12.83% | Upgrade |
D&A For EBITDA | 672 | 636 | 588 | 600 | 462 | 405 | Upgrade |
EBIT | 1,086 | 693 | 803 | 738 | 867 | 985 | Upgrade |
EBIT Margin | 8.00% | 5.32% | 6.38% | 6.02% | 7.41% | 9.10% | Upgrade |
Effective Tax Rate | 30.85% | 22.58% | 82.97% | 44.98% | 31.61% | 32.96% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.